Updates in pediatric kidney transplantation

View at publisher Summarise with VIRAT
Authors: Rachel M. Engen
Cited by: 0
References: 43

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

PURPOSE OF REVIEW: This manuscript highlights key areas of recent pediatric nephrology research that may be relevant to clinical practice. RECENT FINDINGS: Recent reviews of registry data have emphasized the long-term harms of even limited dialysis exposure in children, while studies of 'nonideal' donor kidneys in children have shown positive outcomes. New observational research suggests a benefit to thromboprophylaxis and aggressive fluid management immediately posttransplant, though the best prescriptions remain unclear. Belatacept and letermovir are emerging options for immunosuppression and CMV prophylaxis, respectively, that may have fewer side effects compared to standard of care; interventional studies of these drugs are ongoing. CONCLUSION: Transplant teams should consider using a broader range of donor organs in select pediatric patients. Further interventional research on peritransplant thromboprophylaxis and fluid management is needed to optimize management strategies. The completion of ongoing belatacept and letermovir trials have the potential to substantially alter posttransplant standards of care.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ Donation and Transplantation

Publication details

Journal / source
Current Opinion in Organ Transplantation
Volume
31
Issue
3
Pages
162–166
Publication date
20 March 2026
Language
EN